dupilumab

Chronic hives: Four major clinical trials to watch in 2023
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
chronic hives
chronic urticaria
clinical trials
Sanofi
Regeneron
dupilumab
Amgen
tezepelumab
Allakos
lirentelimab
Celldex Therapeutics
barzolvolimab
Flag link:
Sanofi unveils eczema drug data, as regulators mull label expansion
Sanofi unveils eczema drug data, as regulators mull label expansion
Pharmaforum
Sanofi
Dupixent
dupilumab
eczema
atopic dermatitis
Flag link:
Sanofi and Regeneron boost investment in cancer drug cemiplimab
Sanofi and Regeneron boost investment in cancer drug cemiplimab
Yahoo/Reuters
Sanofi
Regeneron
cemiplimab
cancer
dupilumab
Flag link:
Sanofi indicates dupilumab could be used to treat nasal polyps
Sanofi indicates dupilumab could be used to treat nasal polyps
Yahoo/Reuters
Sanofi
dupilumab
Dupixent
nasal polyps
Flag link:
Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent
Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent
Fierce Pharma
payers
Sanofi
Regeneron
eczema
Dupixent
dupilumab
Flag link:
​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
​FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
FDA
Sanofi Genzyme
Regeneron
Sarilumab
dupilumab
eczema
rheumatoid arthritis
Flag link:
Sanofi and Regeneron report positive skin disease trial
Sanofi and Regeneron report positive skin disease trial
Yahoo/Reuters
Sanofi
Regeneron
dupilumab
monoclonal antibodies
clinical trials
Flag link:
2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful
2 Biotech Companies That Could Profit if Their Skin Treatments Are Successful
TheStreet.com
Regeneron
dupilumab
Anacor
Crisaborole Topical Ointment
psoriasis
eczema
Flag link:
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Regeneron Pharmaceuticals Inc Jumps on Positive Clinical Data
Motley Fool
Regeneron
clinical trials
dupilumab
eczema
atopic dermatitis
Flag link:
Regeneron's Eczema Data Look Great. Don't Believe Me? Ask A Patient
Regeneron's Eczema Data Look Great. Don't Believe Me? Ask A Patient
Forbes
Regeneron
eczema
dupilumab
Flag link:
Sanofi/Regeneron reports glowing phase 2b results for versatile asthma hopeful
Sanofi/Regeneron reports glowing phase 2b results for versatile asthma hopeful
BioPharma Dive
Sanofi
Regeneron
dupilumab
asthma
Flag link:
Regeneron speeds toward the FDA with its would-be asthma blockbuster
Regeneron speeds toward the FDA with its would-be asthma blockbuster
Fierce Biotech
Regeneron
FDA
asthma
dupilumab
Sanofi
Flag link:
Sanofi/Regeneron eczema drug could have limited competition
Sanofi/Regeneron eczema drug could have limited competition
Medical Marketing and Media
Sanofi
Regeneron
eczema
dupilumab
Flag link:
Exclusive: Regeneron, Sanofi outline promising PhIIb data for top blockbuster pick dupilumab
Exclusive: Regeneron, Sanofi outline promising PhIIb data for top blockbuster pick dupilumab
Fierce Biotech
Sanofi
Regeneron
dupilumab
PCSK9 inhibitors
Flag link:
Regeneron says its allergy drug could be as big as PCSK9 blockers
Regeneron says its allergy drug could be as big as PCSK9 blockers
Fierce Pharma
Regeneron
allergies
Sanofi
dupilumab
Flag link:
Sanofi's dual-action biotech asthma drug performs well in test
Sanofi's dual-action biotech asthma drug performs well in test
Yahoo/Reuters
Sanofi
asthma
dupilumab
Regeneron
Flag link:
Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
Yahoo/Reuters
Sanofi
Regeneron
dupilumab
eczema
Flag link:
Sanofi posts positive results for drug in chronic sinusitis
Sanofi posts positive results for drug in chronic sinusitis
Yahoo/Reuters
Sanofi
chronic sinusitis
Regeneron
dupilumab
Flag link:
Regeneron touts its allergy drug as a blockbuster in waiting
Regeneron touts its allergy drug as a blockbuster in waiting
Fierce Biotech
Regeneron
allergy
alirocumab
dupilumab
Flag link:
Sanofi-Regeneron drug tames eczema in study
Sanofi-Regeneron drug tames eczema in study
Yahoo/Reuters
Sanofi
Regeneron
eczema
atopic dermatitis
dupilumab
Flag link:

Pages